Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort

Research output: Contribution to journalArticlepeer-review


  • Ben Parker
  • Murray B Urowitz
  • Dafna D Gladman
  • Mark Lunt
  • Sang-Cheol Bae
  • Jorge Sanchez-Guerrero
  • Juanita Romero-Diaz
  • Daniel J Wallace
  • Ann E Clarke
  • Sasha Bernatsky
  • Ellen M Ginzler
  • David A Isenberg
  • Anisur Rahman
  • Joan T Merrill
  • Graciela S Alarcón
  • Barri J Fessler
  • Paul R Fortin
  • John G Hanly
  • Michelle Petri
  • Kristjan Steinsson
  • Mary-Anne Dooley
  • Susan Manzi
  • Munther A Khamashta
  • Rosalind Ramsey-Goldman
  • Asad A Zoma
  • Gunnar K Sturfelt
  • Ola Nived
  • Cynthia Aranow
  • Meggan Mackay
  • Manuel Ramos-Casals
  • Raymond F van Vollenhoven
  • Kenneth C Kalunian
  • Guillermo Ruiz-Irastorza
  • Sam Lim
  • Diane L Kamen
  • Christine A Peschken
  • Murat Inanc
  • Ian N Bruce

Colleges, School and Institutes


The metabolic syndrome (MetS) may contribute to increased cardiovascular risk in systemic lupus erythematosus (SLE). We aimed to examine the association of demographic factors, lupus phenotype and therapy exposure with the presence of MetS.


Original languageEnglish
Pages (from-to)1308-14
Number of pages7
JournalAnnals of the Rheumatic Diseases
Issue number8
Publication statusPublished - Aug 2013